DRUG TRANSPORT IN THE LIVER - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 408

277. Hedman A, Angelin B, Arvidsson A, Dahlqvist R, Nilsson B. 1990. Interactions in the
renal and biliary elimination of digoxin: stereoselective difference between quinine and
quinidine. Clin Pharmacol Ther 47(1):20-26.
278. Chan LM, Lowes S, Hirst BH. 2004. The ABCs of drug transport in intestine and
liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 21:
25-51.
279. Ho RH, Leake BF, Roberts RL, Lee W, Kim RB. 2004. Ethnicity-dependent polymor-
phism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain
critical for bile acid substrate recognition. J Biol Chem 279:7213-7222.
280. Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, Stieger B. 1997. Substrate specificity
of sinusoidal bile acid and organic anion uptake systems in rat and human liver.
Hepatology 26:1667-1677.
281. Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W, Lemke CJ, Wang Y, Kim RB. 2006.
Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and
pharmacogenetics. Gastroenterology 130:1793-1806.
282. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger
K, Meier PJ, Hagenbuch B. 2001. Organic anion-transporting polypeptide B (OATP-B)
and its functional comparison with three other OATPs of human liver. Gastroenterology
120:525-533.
283. Fischer WJ, Altheimer S, Cattori V, Meier PJ, Dietrich DR, Hagenbuch B. 2005.
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of
microcystin. Toxicol Appl Pharmacol 203:257-263.
284. Su Y, Zhang X, Sinko PJ. 2004. Human organic anion-transporting polypeptide OATP-A
(SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the
vectorial transport of Saquinavir in Hep G2 cells. Mol Pharm 1:49-56.
285. Cui Y, Konig J, Leier I, Buchholz U, Keppler D. 2001. Hepatic uptake of bilirubin and
its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276:
9626-9630.
286. Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M,
Suzuki M, Naitoh T, Matsuno S, Yawo H. 1999. Identification of a novel gene family
encoding human liver-specific organic anion transporter LST-1. J Biol Chem 274:
17159-17163.
287. Tahara H, Kusuhara H, Endou H, Koepsell H, Imaoka T, Fuse E, Sugiyama Y. 2005. A
species difference in the transport activities of H2 receptor antagonists by rat and human
renal organic anion and cation transporters. J Pharmacol Exp Ther 315:337-345.
288. Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, Giacomini KM. 1997. Cloning
and functional expression of a human liver organic cation transporter. Mol Pharmacol
51:913-921.
289. Muller J, Lips KS, Metzner L, Neubert RH, Koepsell H, Brandsch M. 2005. Drug
specificity and intestinal membrane localization of human organic cation transporters
(OCT). Biochem Pharmacol 70:1851-1860.
290. Boyer JL, Meier PJ. 1990. Characterizing mechanisms of hepatic bile acid transport
utilizing isolated membrane vesicles. Methods Enzymol 192:517-533.
291. Wolters H, Spiering M, Gerding A, Slooff MJ, Kuipers F, Hardonk MJ, Vonk RJ. 1991.
Isolation and characterization of canalicular and basolateral plasma membrane fractions
from human liver. Biochim Biophys Acta 1069:61-69.